Zivo Bioscience, Inc.
ZIVO
$14.85
-$0.15-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.05% | -162.97% | 29.41% | 72.46% | -544.22% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.81% | 366.84% | -38.77% | -85.57% | 5,441.33% |
| Change in Net Operating Assets | 282.87% | -377.96% | -178.96% | 140.85% | 106.76% |
| Cash from Operations | 66.69% | -57.91% | 16.53% | -73.96% | 63.29% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -117.55% | 38.69% | 21.33% | 0.00% | -200.00% |
| Issuance of Common Stock | -- | -- | 71.40% | 114.32% | -40.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -107.65% | -82.31% | 84.28% | 154.77% | -68.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.51% | -174.14% | 781.45% | 215.20% | -0.37% |